Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Alcon Research
Subjects will attend 9 scheduled study visits for a total individual duration of participation of approximately 6 months. The primary endpoint will be assessed at the Month 2 follow-up visit. Both eyes of a subject must qualify for enrollment into this study.
Age
22–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Understand and sign an ethics committee-approved informed consent form;
Willing and able to attend all scheduled study visits as required by the protocol;
Planned cataract surgery (both eyes);
Preoperative corneal astigmatism less that 1.00 diopter in each eye.
You may not be if
Women of childbearing potential if currently pregnant, intend to become pregnant during the study, or are breastfeeding;
Ocular conditions as specified in the protocol;
Subjects who desire monovision correction.
Clareo Health | Clareon PanOptix Pro vs. Clareon PanOptix - Study B
